EPISODE · May 29, 2018 · 7 MIN
Multiple Myeloma Joins the Car T Race
from Journal of Clinical Oncology (JCO) Podcast · host Michael W. Becker
Highlighting the importance of BCMA-CAR T therapy for patients with relapsed refractory multiple myeloma and discusses future avenues of clinical investigation. Read the related article "T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma" on JCO.org
NOW PLAYING
Multiple Myeloma Joins the Car T Race
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m